Search Data.gov
Found 135 dataset(s) matching "fda".
-
2008-2024. American Lung Association. Cessation Coverage. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State...
-
Marker residue depletion from the skin-on fillet tissue of rainbow trout exposed to AQUI S 20E: Data
Among the data required by the U.S. Food and Drug Administration (FDA) for approval of an aquaculture drug are the data that characterize the depletion of a drugs marker residue from the edible...
-
<p>The Vaccine Adverse Event Reporting System (VAERS) online database on CDC WONDER provides counts and percentages of adverse event case reports after vaccination, received since January 1990...
-
The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is a prospective, randomized, multicenter clinical trial of carotid endarterectomy (CEA) versus carotid artery stenting...
-
This feed provides new health and safety updates related to FDA approved products
-
<p>Research projects funded by the National Institutes of Health (NIH), other DHHS Operating Divisions (ACF, AHRQ, CDC, FDA, HRSA), and the Department of Veterans Affairs. The ExPORTER files...
-
This blog post was posted on September 4, 2015 and written by Taha Kass-Hout, M.D., M.S., Roselie A. Bright, Sc.D., M.S., P.M.P. and Ann Ferriter. It is a cross post from FDA Voice.
-
Public access allowing for public search of the FDA Adverse Events Database
-
This list includes products subject to recall since September 2010 related to infant formula distributed by Abbott. This list will be updated with publicly available information as received. The...
-
This list includes food subject to recall in the United States since March 2009 related to pistachios distributed by Setton Pistachio of Terra Bella, Inc. The FDA has completed its inspection of...
-
The publication Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book) identifies drug products approved on the basis of safety and...
-
This database contains the commercially marketed in vitro test systems categorized as CLIA waived by the FDA since January 31, 2000, and by the Centers for Disease Control and Prevention (CDC)...
-
This database contains the commercially marketed in vitro test systems categorized by the FDA since January 31, 2000, and tests categorized by the Centers for Disease Control and Prevention (CDC)...
-
On November 16, 1988, the President of the United States signed into law the Generic Animal Drug and Patent Restoration Act (GADPTRA). Among its major provisions, the Act extends eligibility for...
-
The FDA shall publish in a format that is understandable and not misleading to a lay person, and place on public display, a list of 93 harmful and potentially harmful constituents in each tobacco...
-
Companies are required under Section 506C of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (as amended by the Food and Drug Administration Safety and Innovation Act) to notify FDA of a...
-
A 180-day supplement is a request for a significant change in components, materials, design, specification, software, color additive, and labeling to an approved premarket application or premarket...
-
An index of FDA warning letters issued to companies operating in the United States.
-
This feed describes all new items that are being recalled by the FDA.
-
The Food and Drug Administration Amendments Act of 2007 gave FDA the authority to require a Risk Evaluation and Mitigation Strategy (REMS) from manufacturers to ensure that the benefits of a drug...
